Improving access to plant-based medicines for human health
Official title: Multi-omics approaches to lower the barriers to sustainable production of plant natural products with relevance to human health
Funded at University of Georgia · NIH-11041049 · Data updated 2026-11-12
This study is all about finding better ways to help plants produce natural compounds that are good for your health, so we can make more effective medicines from them for people who need new treatments.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Georgia NIH-funded |
| Lab location | 1 site (Athens, United States) |
| Project start | March 1, 2024 |
| Project end | December 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $485,272 |
| NIH project number | 5R01AT012783-02 |
| Project ID | NIH-11041049 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who may benefit from new or improved plant-derived medications for conditions such as cancer or inflammation.
✕Less likely to help
Patients who do not have conditions that can be treated with plant-derived compounds may not receive any benefit from this research.
What this research studies
This research focuses on enhancing the production of natural compounds from plants that are important for human health. By using advanced techniques in genomics and metabolic engineering, the project aims to identify and optimize the pathways that plants use to create these beneficial molecules. The goal is to make these compounds more accessible for pharmaceutical use, which could lead to new treatments for various diseases. Patients may benefit from improved availability of effective plant-derived medications.
Why it matters
Potential benefit: If successful, this research could lead to increased availability of plant-based pharmaceuticals that treat a variety of health conditions.
How similar studies have gone: While there have been some successful applications of metabolic engineering in microbial systems, the approach of using next-generation omics technologies for plant natural products is still relatively novel.
Where this research is happening
-
University of Georgia
Athens, United States Active
Researchers
- Principal investigator: Buell, Carol Robin — University of Georgia
- Study coordinator: Buell, Carol Robin
Related research
Other NIH-funded projects on the same topics.
-
BRD4 and NIPBL work together to control facial bone development
A study in mice and cell models will explore how BRD4 and NIPBL work together to control how genes are turned on in facial development, which could clarify causes of craniofacial disorders.
-
Sulfated glycosaminoglycan hydrogels to protect brain volume after traumatic injury
A new implantable gel made from specially sulfated sugars may help prevent brain shrinkage and improve function after a serious brain injury.
-
Understanding how Kaposi’s sarcoma virus switches on late genes during infection
Scientists are studying how the virus causing Kaposi’s sarcoma turns on late genes when its DNA copies itself, which could reveal new ways to treat cancer in people with AIDS.
-
Understanding how cells control signals and adhesion with the secretory pathway
A funded NIH project looks at how the cell’s secretory system shapes signals, receptors, and attachment to the outside of the cell, which can influence many human diseases.
-
AI-powered math and machine learning for bioscience and drug discovery
A broad NIH grant supports using advanced math and AI to better predict viral variants and aid drug discovery, with the goal of helping patients by accelerating pandemic response.
-
AI-driven platform to predict vaccine-escape variants and design mutation-proof antibodies
An AI-powered approach aims to anticipate SARS-CoV-2 variants that may dodge vaccines and to create antibodies that stay effective.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.